Brazil Healthcare Market Analysis

Brazil is one of the most lucrative healthcare markets in Latin America. Backed by factors, such as strong government support and high investments, Brazilian healthcare market is growing at a fast pace. Almost all the market players have been trying to bring positive developments in healthcare services through proper implementation of plans and policies. As there is effective strong demand for primary health care level drugs, such as generics, antibiotics, and OTC, healthcare expenditure is believed to grow to around US$ 201.6 Billion by 2013, representing a CAGR of around 6% during 2010-2013.

The government has been playing a key role in broadening the horizon and revenue patterns of the healthcare industry. With the proper launch of several effective programs, such as Smiling Brazil and UPA 24 Hours, the government has also ensured the better implementation of these kinds of healthcare policies. Investment, management of resources, awareness building are some of the key goals under such programs. Primary healthcare has been one of the major focus areas, as the country still faces concerns regarding disease prevalence and basic services.

The future outlook of healthcare industry is quite optimistic as companies are investing huge amounts of money in information technology, innovative medical equipments, and clinical research. Moreover, world’s leading healthcare providers are looking towards Brazil as an ideal destination for further expansion, as people are becoming more health conscious and there is a large growth potential. In such a scenario, the sector offers significant attraction to several stakeholders, and those participating in the industry developments.

The report “Brazil Healthcare Market Analysis” covers all the necessary aspects of the Brazilian healthcare market, providing an in-depth research and prudent analysis of the key segments. The segments covered in the report include: Hospital Services Industry, Pharmaceutical Industry, Medical Devices Industry, and Other emerging market segments. The report presents an insight into the current industry trends; key market drivers, and the government initiatives to enable clients understand the market structure and its expected progress in coming years. The report also covers the description, strengths & weaknesses of the active market players.
[Fade out the market survey infos]

1. Analyst View
2. Healthcare Market Overview
3. Market Drivers
3.1 Favorable Demographics
3.2 Epidemiology
3.3 Government Initiatives
3.4 Private Sector Investments
3.5 Infrastructure and R&D
4. Industry Performance
4.1 Pharmaceutical Market
4.1.1 Market Overview
4.1.2 Generic Drugs
4.1.3 Import and Export
4.1.4 Prescription and OTC Drugs
4.2 Medical Device Industry
4.3 Hospital Services Industry
4.4 Primary Care
4.4.1 Oral Health
4.4.2 Family Health
5. Emerging Market Trends
5.1 Health Insurance Industry
5.2 Medical Tourism Industry
5.3 Clinical Trials Industry
5.4 Biotechnology
5.5 Healthcare-IT Market
6. Regulatory Environment
7. Government Healthcare Programs
8. Industry Restraints
8.1 Tax System
8.2 Substandard Hospitals
9. Competitive Landscape
9.1 Leading Players
9.1.1 Hospital Services
9.1.2 Pharmaceuticals
9.1.3 Medical Devices

List of Figures:

Figure 2-1: Healthcare Expenditure (Billion US$), 2009-2013
Figure 3-1: Share of Population Diagnosed with Hypertension (2006 & 2009)
Figure 3-2: Prevalence of Hypertension in Population Aged 65 Years & Above (2006 & 2009)
Figure 3-3: Share of Population with Obesity (2006 & 2009)
Figure 4-1: Share of Brazilian Pharmaceutical Market in Latin America (2010)
Figure 4-2: Pharmaceutical Market (Billion BRL), 2008-2010
Figure 4-3: Pharmaceutical Market (Billion Units), 2008 & 2009
Figure 4-4: Share of Domestic and Foreign Capital in Pharmaceutical Retail Market (2009)
Figure 4-5: Global - Pharmaceutical Market Ranking (2009 & 2011)
Figure 4-6: Forecast for Pharmaceutical Market (Billion BRL), 2011-2013
Figure 4-7: Share of Generics in Pharmaceutical Market (2009)
Figure 4-8: Generic Drugs Market (Billion BRL), 2009-2011
Figure 4-9: Generic Drugs Market (Million Units), 2009 & 2010
Figure 4-10: Pharmaceutical Imports (Billion US$), 2007-2009
Figure 4-11: Pharmaceutical Exports (Million US$), 2007-2009
Figure 4-12: Share of OTC Drugs in Pharmaceutical Market (2009)
Figure 4-13: Medical Device Market (Billion US$), 2007-2010
Figure 4-14: Medical Device Imports (Billion US$), 2007-2009
Figure 4-15: Medical Device Exports (Million US$), 2007-2009
Figure 4-16: Number of Doctors (‘000), 2009-2013
Figure 4-17: Share of Physicians in Private Sector (March 2009)
Figure 4-18: Dental Schools by Sector (%), 2010
Figure 4-19: Number of Oral Health Teams (2007-2009)
Figure 4-20: Coverage of Community Agents Program (PACS) and Family Health Program (PSF) (%), 2007-2009
Figure 4-21: Prenatal Basic Health Units by Region (%), 2008
Figure 5-1: Health Insurance Market (Billion US$), 2007-2009
Figure 5-2: Number of Clinical Trials (2000 & 2008)
Figure 8-1: Tax Rate on Medicines in Brazil, Argentina and Germany (%)

List of Tables:

Table 3-1: Demographic Characteristics (2009-2012)
Table 3-2: Breakup of Obese People by Age Group
Table 4-1: Leading Pharmaceutical Companies by Sales (Million US$)
Table 4-2: Leading Drugs by Sales (Million US$)
Table 5-1: Cost of Various Surgical Procedures in Comparison to United States (US$)
Table 7-1: Key Goals under Various Parts of UPA 24 Hours Program
Table 9-1: São Luiz - Strengths & Weaknesses
Table 9-2: Sanofi-Aventis - Strengths & Weaknesses
Table 9-3: Bayer - Strengths & Weaknesses
Table 9-4: Novartis - Strengths & Weaknesses
Table 9-5: Pfizer - Strengths & Weaknesses
Table 9-6: 3M - Strengths & Weaknesses
Table 9-7: AGFA - Strengths & Weaknesses
[Fade out table of contents]